fatty liver disease and semaglutide effectively treats in two thirds of patients, research finds Focus on Semaglutide 2.4 mg/week

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist , primarily used to manage Type 2 diabetes and facilitate weight loss in individuals who are overweight or have obesity-related health conditions

Discover how HRT enhances GLP-1 weight loss in menopause while easing symptoms like hot flashes, sleep issues, and mood changes

Gamma-Glutamyltransferase (GGT)

Increasingly, reports suggest a possible association between GLP-1 RA use and enhanced fertility outcomes, particularly in women with obesity or polycystic ovary syndrome (PCOS)

Our job as clinicians is to protect what matters inside it

I reported it to Meta and the group has now been removed